XML 72 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
 12 Months Ended
Dec. 31, 2015
Earnings Per Share [Abstract]  
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
The following table provides the detailed calculation of Earnings per common share (EPS):
 
 
Year Ended December 31,
(IN MILLIONS)
 
2015

 
2014

 
2013

EPS Numerator––Basic
 
 

 
 
 
 
Income from continuing operations
 
$
6,975

 
$
9,119

 
$
11,410

Less: Net income attributable to noncontrolling interests
 
26

 
32

 
30

Income from continuing operations attributable to Pfizer Inc.
 
6,949

 
9,087

 
11,380

Less: Preferred stock dividends––net of tax
 
1

 
1

 
2

Income from continuing operations attributable to Pfizer Inc. common shareholders
 
6,948

 
9,086

 
11,378

Discontinued operations––net of tax
 
11

 
48

 
10,662

Less: Discontinued operations––net of tax, attributable to noncontrolling interests
 
—

 
—

 
39

Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders
 
11

 
48

 
10,623

Net income attributable to Pfizer Inc. common shareholders
 
$
6,959

 
$
9,134

 
$
22,001

EPS Numerator––Diluted
 
 

 
 

 
 
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
6,948

 
$
9,087

 
$
11,380

Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions
 
11

 
48

 
10,623

Net income attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
6,960

 
$
9,135

 
$
22,003

EPS Denominator
 
 

 
 

 
 
Weighted-average number of common shares outstanding––Basic
 
6,176

 
6,346

 
6,813

Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreement
 
81

 
78

 
82

Weighted-average number of common shares outstanding––Diluted
 
6,257

 
6,424

 
6,895

Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a)
 
50

 
44

 
43

(a) 
These common stock equivalents were outstanding for the years ended December 31, 2015, 2014 and 2013, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.